Evidence map›Paper›PMID 24849358›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2014

The systemic amyloid precursor transthyretin (TTR) behaves as a neuronal stress protein regulated by HSF1 in SH-SY5Y human neuroblastoma cells and APP23 Alzheimer's disease model mice.

Xin Wang, Francesca Cattaneo, Lisa Ryno, John Hulleman, Natàlia Reixach, Joel N Buxbaum

Open access · hybridAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Xin WangDepartment of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California 92037, and.
Francesca CattaneoDepartment of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California 92037, and Department of Life Sciences, University of Siena, 53100 Siena, Italy.
Lisa RynoDepartment of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California 92037, and.
John HullemanDepartment of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California 92037, and.
Natàlia ReixachDepartment of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California 92037, and.
Joel N BuxbaumDepartment of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California 92037, and jbux@scripps.edu.
Scripps Research Institute · USUniversity of Siena · IT

Funding

Aging and the Tissue Response to Misfolded ProteinsR01AG030027 · NIA · SCRIPPS RESEARCH INSTITUTE, THE · PI BUXBAUM, JOEL N · 2008 to 2012
$2.1M
NIA NIH HHS AG R01 030027
6 · The paper itself

Abstract

Increased neuronal synthesis of transthyretin (TTR) may favorably impact on Alzheimer's disease (AD) because TTR has been shown to inhibit Aβ aggregation and detoxify cell-damaging conformers. The mechanism whereby hippocampal and cortical neurons from AD patients and APP23 AD model mice produce more TTR is unknown. We now show that TTR expression in SH-SY5Y human neuroblastoma cells, primary hippocampal neurons and the hippocampus of APP23 mice, is significantly enhanced by heat shock factor 1 (HSF1). Chromatin immunoprecipitation (ChIP) assays demonstrated occupation of TTR promoter heat shock elements by HSF1 in APP23 hippocampi, primary murine hippocampal neurons, and SH-SY5Y cells, but not in mouse liver, cultured human hepatoma (HepG2) cells, or AC16 cultured human cardiomyocytes. Treating SH-SY5Y human neuroblastoma cells with heat shock or the HSF1 stimulator celastrol increased TTR transcription in parallel with that of HSP40, HSP70, and HSP90. With both treatments, ChIP showed increased occupancy of heat shock elements in the TTR promoter by HSF1. In vivo celastrol increased the HSF1 ChIP signal in hippocampus but not in liver. Transfection of a human HSF1 construct into SH-SY5Y cells increased TTR transcription and protein production, which could be blocked by shHSF1 antisense. The effect is neuron specific. In cultured HepG2 cells, HSF1 was either suppressive or had no effect on TTR expression confirming the differential effects of HSF1 on TTR transcription in different cell types.

Indexed as

Alzheimer DiseaseAmyloid beta-Protein PrecursorAnimalsCarcinoma, HepatocellularCells, CulturedDisease Models, AnimalDNA-Binding ProteinsEmbryo, MammalianGene Expression Regulation, NeoplasticHeat-Shock ProteinsHeat Shock Transcription FactorsHippocampusHumansLiver NeoplasmsMiceMice, Inbred C57BLAmyloid beta-Protein PrecursorDNA-Binding ProteinsHeat-Shock ProteinsHeat Shock Transcription FactorsHSF1 protein, humanOligonucleotides, AntisensePrealbuminTranscription FactorsAlzheimer's diseasecelastrolheat shockHSF1transgenicstransthyretin

Identifiers

PMID24849358
PMCPMC4028500
OpenAlexW2139301811

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.